These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

943 related items for PubMed ID: 15716217

  • 1. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL, Freeman A, Ingram CD, Rye DB, Chakravorty S, Watts RL.
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [Abstract] [Full Text] [Related]

  • 2. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J, Karrasch J, Haan J, Volc D.
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [Abstract] [Full Text] [Related]

  • 3. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP, Ritchie SY.
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [Abstract] [Full Text] [Related]

  • 4. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K, TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group.
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L, Ritchie SY, Kirsch JM.
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [Abstract] [Full Text] [Related]

  • 6. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [Abstract] [Full Text] [Related]

  • 7. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
    Fulda S, Wetter TC.
    Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
    [Abstract] [Full Text] [Related]

  • 8. Ropinirole treatment for restless legs syndrome.
    Bogan RK.
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [Abstract] [Full Text] [Related]

  • 9. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L, Asgharian A, Hunter B.
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [Abstract] [Full Text] [Related]

  • 10. Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome.
    Benes H.
    Sleep Med; 2006 Jan; 7(1):31-5. PubMed ID: 16194624
    [Abstract] [Full Text] [Related]

  • 11. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.
    Garcia-Borreguero D, Grunstein R, Sridhar G, Dreykluft T, Montagna P, Dom R, Lainey E, Moorat A, Roberts J.
    Sleep Med; 2007 Nov; 8(7-8):742-52. PubMed ID: 17512789
    [Abstract] [Full Text] [Related]

  • 12. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L, Hirvonen K, Partinen M, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [Abstract] [Full Text] [Related]

  • 13. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC, Dahmen MM, Makos M, Lea JW, Carver LJ, Rasu RS.
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [Abstract] [Full Text] [Related]

  • 14. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.
    Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [Abstract] [Full Text] [Related]

  • 16. Relationship of periodic leg movements and severity of restless legs syndrome: a study in unmedicated and medicated patients.
    Hornyak M, Hundemer HP, Quail D, Riemann D, Voderholzer U, Trenkwalder C.
    Clin Neurophysiol; 2007 Jul; 118(7):1532-7. PubMed ID: 17531532
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH, Benes H, Bodenschatz R, Peglau I, Warmuth R, Happe S, Geisler P, Cassel W, Leroux M, Kohnen R, Stiasny-Kolster K.
    Neurology; 2006 Sep 26; 67(6):1040-6. PubMed ID: 16931508
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of ropinirole for RLS and depressive symptoms in an 11-year-old girl.
    Cortese S, Konofal E, Lecendreux M.
    Sleep Med; 2009 Feb 26; 10(2):259-61. PubMed ID: 18291718
    [Abstract] [Full Text] [Related]

  • 19. [The efficacy of ropinirole in the treatment of chronic insomnia secondary to restless legs syndrome: polysomnography data].
    Estivill E, de la Fuente V.
    Rev Neurol; 2009 Feb 26; 29(9):805-7. PubMed ID: 10696651
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.
    Garcia-Borreguero D, Winkelman J, Adams A, Ellis A, Morris M, Lamb J, Layton G, Versavel M, Sumanirole in RLS Study Group.
    Sleep Med; 2007 Mar 26; 8(2):119-27. PubMed ID: 17239657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.